黄芪提取物TA-65通过线粒体TERT对新生鼠缺氧缺血性脑损伤的神经保护及安全性
本研究在体内外新生鼠缺氧缺血性脑损伤(HIBD)模型中探究黄芪提取物TA-65的神经保护作用及TERT机制。TA-65上调线粒体TERT表达而不影响核TERT,减少神经元凋亡和脑梗死面积,改善神经功能,且未改变端粒长度、未影响体重、随机血糖、血细胞计数、肝肾功能和免疫功能,未导致重要器官肿瘤发生。
要点
- TA-65上调HIBD后线粒体TERT表达,不影响核TERT。
- TA-65减少神经元凋亡和脑梗死面积,改善神经功能。
- TA-65未改变端粒长度,未影响体重、血糖、血细胞、肝肾功能和免疫,未致肿瘤。
核心结论
- TA-65在新生HIBD中发挥神经保护作用,无显著副作用或致瘤性,机制可能涉及增强线粒体TERT表达。
研究设计与样本
- 建立体内和体外HIBD模型并用TA-65处理,通过western blotting和免疫荧光检测核与线粒体TERT表达,评估脑梗死面积和神经元凋亡及小鼠神经功能,并通过体重、随机血糖、血细胞计数、肝肾功能、免疫功能及重要器官肿瘤检测评估TA-65安全性。
主要发现
- TA-65在体内和体外均上调HIBD后线粒体TERT表达,但不影响核TERT表达。
- TA-65减少HIBD后小鼠神经元凋亡和脑梗死面积,改善神经功能。
- TA-65未改变脑内端粒长度,未影响HIBD后小鼠体重、随机血糖水平、血细胞计数、肝肾功能或免疫功能。
- TA-65未导致小鼠重要器官肿瘤发生。
临床怎么用
- TA-65作为黄芪提取物在新生HIBD模型中显示神经保护作用且安全性良好,机制与线粒体TERT相关,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Astragalus membranaceus is one of the most widely applied traditional Chinese herbal medicines. TA-65 is an extract of Astragalus membranaceus; however, the protective effects of TA-65 in brain damage during development remain unclear. AIM OF THE STUDY: To investigate the neuroprotective effects of TA-65 in a neonatal hypoxic-ischemic brain damage (HIBD) mouse model, focusing on the role of telomerase reverse transcriptase (TERT). MATERIALS AND METHODS: In vivo and in vitro HIBD models were established and treated with TA-65. Nuclear and mitochondrial TERT expressions were measured by western blotting and immunofluorescence. Brain injury was evaluated through the measurement of brain infarction areas and neuronal apoptosis. The neurological function of mice was assessed. TA-65 safety was evaluated by measuring mouse body weight, random blood glucose level, blood cell count, liver and kidney function, and immune function, as well as detecting tumor occurrence in vital organs. RESULTS: TA-65 administration upregulated mitochondrial TERT expression after HIBD both in vivo and in vitro, but did not influence nuclear TERT expression. TA-65 reduced neuronal apoptosis and brain infarction areas, and improved neurological function in mice after HIBD. TA-65 did not change telomere length in the brain or affect body weight, random blood glucose levels, blood cell counts, liver and kidney function, or immune function in mice after HIBD. TA-65 administration did not cause tumor occurrence in the vital organs of mice. CONCLUSIONS: TA-65 exerts neuroprotective effects in neonatal HIBD without significant side effects or tumorigenicity. The possible mechanism may involve enhanced mitochondrial TERT expression.
引用
- Li J, Fang Z, Shi J, et al. Neuroprotection and safety profile of Astragalus membranaceus extract TA-65 in neonatal hypoxic-ischemic brain damage by activating mitochondrial telomerase reverse transcriptase: Evidence from in vitro and in vivo studies. J Ethnopharmacol. 2025. PMID: 40456473. doi:10.1016/j.jep.2025.120073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。